The Glasgow Royal Infirmary is a large teaching hospital. With a capacity of around 1,000 beds, the hospital campus covers an area of around 8 hectares, situated on the north-eastern edge of the city centre of Glasgow, Scotland. It is managed by NHS Greater Glasgow and Clyde.

There are 1,077 beds in Glasgow Royal Infirmary.

During the past decade, Glasgow Royal Infirmary conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 20 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 14 clinical trials were completed. i.e. 37.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Glasgow Royal Infirmary" #1 sponsor was "NHS Greater Glasgow and Clyde" with 21 trials, followed by "University of Edinburgh" with 8 trials sponsored, "University of Glasgow" with 5 trials sponsored, "Glasgow Royal Infirmary" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 79 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glasgow Royal Infirmary" #1 collaborator was "University of Glasgow" with 15 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 6 trials as a collaborator, "Chief Scientist Office of the Scottish Government" with 5 trials as a collaborator, "NHS Lothian" with 5 trials as a collaborator and "British Heart Foundation" with 2 trials as a collaborator. Other collaborators include 97 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Glasgow Royal Infirmary" are "Breast Cancer" (8 trials), "Hemophilia B" (5 trials), "Crohn Disease" (4 trials), "Heart Failure" (4 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Glasgow Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Glasgow Royal Infirmary" are "Drug" (68 trials), "Procedure" (22 trials), "Other" (21 trials), "Biological" (16 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "cyclophosphamide" (7 trials), "fluorouracil" (5 trials), "radiation therapy" (5 trials) and "adjuvant therapy" (4 trials). Other intervention names were less common.

The vast majority of trials in "Glasgow Royal Infirmary" are 104 trials for "All" genders, 14 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 35 active trials in "Glasgow Royal Infirmary". 1 are not yet recruiting, 19 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 63 completed trials in Glasgow Royal Infirmary, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Glasgow Royal Infirmary, 2 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 32 trials that are defined as “Not Applicable".